Research workbench
Bso-inhibited scgcl
Analyse Bso-inhibited scgcl in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 3LVV
- Type
- protein
- Length
- 672 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Glutamate--cysteine ligase
- EC
- 6.3.2.2
- UniProt
- P32477
- Ligands
- LBP, ADP, MG
- Pockets
- 5 · best druggability 0.72
Structure
x-ray diffraction · 1 distinct chain · 41% helix, 13% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Glutamate--cysteine ligase (EC 6.3.2.2) | protein | 672 | 41% helix, 13% strand | P32477 |
Ligands and binding sites
- LBP · (2S)-2-amino-4-(S-butyl-N-phosphonosulfonimidoyl)butanoic acid · ligand · chains A
- ADP · Adenosine-5'-diphosphate · ligand · chains A
- MG · Magnesium ion · metal · 3 copies · chains A
- PGE · Triethylene glycol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 727 | 0.72 | 0.78 | 68 | LBP, ADP, MG |
| 2 | 146 | 0.59 | 0.84 | 25 | empty |
| 3 | 328 | 0.56 | 0.75 | 32 | empty |
| 4 | 117 | 0.42 | 0.76 | 28 | PGE |
| 5 | 57 | 0.27 | 0.74 | 14 | empty |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P32477
- Elsewhere: RCSB PDB 3LVV · PDBe 3LVV · UniProt P32477
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.